CutiCeuticals Gets Patent for Psoriasis, Eczema Treatment

CutiCeuticals has been granted a patent for its CutiCort Spray.

The product is a .05 percent clobetasol aerosol spray used for the treatment of psoriasis, eczema and other inflammatory skin conditions.